TY  - JOUR
AU  - Valldeoriola, Francesc
AU  - Catalán, María José
AU  - Escamilla-Sevilla, Francisco
AU  - Freire, Eric
AU  - Olivares, Jesús
AU  - Cubo, Esther
AU  - García, Diego Santos
AU  - Calopa, Matilde
AU  - Martínez-Martín, Pablo
AU  - Parra, Juan Carlos
AU  - Arroyo, Gloria
AU  - Arbelo, José Matías
PY  - 2021
DO  - 10.1038/s41531-021-00246-y
SN  - 2373-8057
UR  - https://hdl.handle.net/10668/24983
T2  - NPJ Parkinson's disease
AB  - Levodopa-carbidopa intestinal gel (LCIG) has shown to be efficacious in motor and non-motor symptoms (NMS). Nevertheless, studies with patient Quality of Life (QoL) as a primary endpoint are scarce. To assess the effect of LCIG on Advanced Parkinson's...
LA  - en
TI  - Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
TY  - research article
VL  - 7
ER  -